37 results
8-K
CMMB
Chemomab Therapeutics Ltd
11 Feb 22
Submission of Matters to a Vote of Security Holders
6:01am
meeting of its shareholders (the “Special Meeting”). There were 89,749,560 ordinary shares of the Company represented by proxy at the Special Meeting, constituting … approximately 39.35% of the outstanding ordinary shares on January 4, 2022, the record date for the Special Meeting.
The sole matter
8-K
CMMB
Chemomab Therapeutics Ltd
26 Oct 21
Submission of Matters to a Vote of Security Holders
4:02pm
a special general meeting of its shareholders (the “Special Meeting”). There were 97,437,080 ordinary shares of the Company represented by proxy … at the Special Meeting, constituting approximately 42.74% of the outstanding ordinary shares on October 1, 2021, the record date for the Special Meeting
8-K
x1cw9jh0
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
425
ix17ufkyi8tnbmtqxz
10 Mar 21
Business combination disclosure
12:00am
8-K
7mr735p6biyk phjn4l
10 Mar 21
Other Events
12:00am
424B3
o6qghhxno
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
fjdhy8cel1h5b t1h6d
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
8-K
qrkj2rweq65j uti
8 Feb 21
Other Events
2:17pm
425
wjv11h9d2w7s8z
8 Feb 21
Business combination disclosure
2:15pm
S-4
rblv78qx tj1
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.1
f1ophwroo
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-3.1
ro97 j75kj735u1dco
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-99.1
v6yd8cabljoie
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-99.1
w69 8qgeo
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEF 14A
v8emjjwk
6 Apr 20
Definitive proxy
6:11am
PRE 14A
wqyzwh2o3pdwf04t0
30 Mar 20
Preliminary proxy
5:03pm